Flumedroxone acetate

From WikiMD's WELLNESSPEDIA

Flumedroxone_acetate.svg

Flumedroxone acetate is a synthetic progestin and androgen that has been used in hormone therapy and contraception. It is a derivative of progesterone and has been studied for its potential applications in various medical conditions.

Chemical Structure and Properties[edit]

Flumedroxone acetate is chemically classified as a steroid and has the molecular formula C_24H_31FO_4. It is a fluorinated derivative of medroxyprogesterone acetate, which enhances its biological activity. The compound is characterized by the presence of an acetate group, which influences its pharmacokinetics and bioavailability.

Pharmacology[edit]

As a progestin, flumedroxone acetate mimics the effects of natural progesterone in the body. It binds to progesterone receptors in target tissues, leading to changes in gene expression and cellular function. This action is crucial in regulating the menstrual cycle, maintaining pregnancy, and modulating immune response.

In addition to its progestogenic activity, flumedroxone acetate exhibits weak androgenic properties. This dual activity makes it useful in certain therapeutic contexts, such as hormone replacement therapy and the treatment of endometriosis.

Medical Uses[edit]

Flumedroxone acetate has been investigated for several medical applications, including:

Side Effects[edit]

Like other progestins, flumedroxone acetate can cause a range of side effects, including:

Synthesis[edit]

The synthesis of flumedroxone acetate involves the fluorination of medroxyprogesterone acetate, followed by acetylation. This process enhances its stability and bioavailability, making it suitable for clinical use.

Regulatory Status[edit]

Flumedroxone acetate is not widely available and is subject to regulatory approval in various countries. Its use is typically restricted to specific medical conditions and requires a prescription from a licensed healthcare provider.

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.